5/15
11:19 am
halo
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
5/8
03:19 pm
halo
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
02:42 pm
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at JMP Securities from $72.00 to $71.00. They now have a "market outperform" rating on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at JMP Securities from $72.00 to $71.00. They now have a "market outperform" rating on the stock.
5/8
11:40 am
halo
Biopharmaceuticals Packaging Market Size Expected to Reach USD 42.08 Bn by 2032 Wed, May 8, 2024, 5:32 PM GMT+2 17 min read 0 Advertisement Up next Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates Wed, May 8, 2024, 4:34 PM GMT+2 3 min read 0 In
Low
Report
Biopharmaceuticals Packaging Market Size Expected to Reach USD 42.08 Bn by 2032 Wed, May 8, 2024, 5:32 PM GMT+2 17 min read 0 Advertisement Up next Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates Wed, May 8, 2024, 4:34 PM GMT+2 3 min read 0 In
5/8
08:40 am
halo
Halozyme to Participate in Upcoming Investor Conferences Wed, May 8, 2024, 2:30 PM GMT+2 2 min read 0 In this article: Advertisement Up next Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Wed, May 8, 2024, 12:00
Low
Report
Halozyme to Participate in Upcoming Investor Conferences Wed, May 8, 2024, 2:30 PM GMT+2 2 min read 0 In this article: Advertisement Up next Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Wed, May 8, 2024, 12:00
5/8
08:30 am
halo
Halozyme to Participate in Upcoming Investor Conferences
Low
Report
Halozyme to Participate in Upcoming Investor Conferences
5/7
08:10 pm
halo
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
5/7
04:19 pm
halo
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS [Yahoo! Finance]
Low
Report
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS [Yahoo! Finance]
5/7
04:01 pm
halo
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Low
Report
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
5/7
08:01 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
5/6
10:48 am
halo
Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]
Low
Report
Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]
5/3
04:32 am
halo
How Novo-Catalent Deal Affects Halozyme (HALO)? [Yahoo! Finance]
Low
Report
How Novo-Catalent Deal Affects Halozyme (HALO)? [Yahoo! Finance]
4/30
08:12 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
4/25
04:52 pm
halo
Mahesh Krishnan Elected to Halozyme's Board of Directors [Yahoo! Finance]
Low
Report
Mahesh Krishnan Elected to Halozyme's Board of Directors [Yahoo! Finance]
4/25
04:45 pm
halo
Mahesh Krishnan Elected to Halozyme's Board of Directors
Low
Report
Mahesh Krishnan Elected to Halozyme's Board of Directors
4/23
11:08 am
halo
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
4/23
08:47 am
halo
Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]
Low
Report
Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]
4/23
08:30 am
halo
Halozyme to Report First Quarter 2024 Financial and Operating Results
Low
Report
Halozyme to Report First Quarter 2024 Financial and Operating Results
4/18
01:52 pm
halo
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Low
Report
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
4/16
10:13 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $50.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $50.00 price target on the stock.
4/16
01:04 am
halo
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease [Yahoo! Finance]
Low
Report
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease [Yahoo! Finance]
4/10
07:00 am
halo
Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics [Seeking Alpha]
Low
Report
Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics [Seeking Alpha]
4/4
07:28 am
halo
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist? [Yahoo! Finance]
Medium
Report
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist? [Yahoo! Finance]
3/28
01:18 pm
halo
Xeris gains as Oppenheimer highlights drug technology [Seeking Alpha]
Low
Report
Xeris gains as Oppenheimer highlights drug technology [Seeking Alpha]
3/21
01:38 pm
halo
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report? [Yahoo! Finance]